Glucagon is considered the drug of choice for treating bradycardia and hypotension encountered during β-blocker poisoning. Its potential usefulness is reversing adverse effects encountered during therapeutic dosing with β-blocker has not been well characterized. We present a case of sotalol-induced bradycardia reversed by glucagon.
|Original language||English (US)|
|Journal||Canadian Family Physician|
|State||Published - Jan 1 1995|
ASJC Scopus subject areas
- Family Practice